Xcout IntelSign inSubscribe

PolyPeptide Group AG competitors & alternatives

0AAJPharmaceuticalsBaar, Switzerland

The 12 closest competitors and alternatives to PolyPeptide Group AG among pharmaceuticals companies — ranked by similarity to what PolyPeptide Group AG actually does, not by market-cap band.

$1.8BMarket cap
1,362Employees
12Competitors listed

Subscribe to see PolyPeptide Group AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About PolyPeptide Group AG

Operating globally, PolyPeptide Group AG functions as a prominent contract development and manufacturing organization (CDMO). The company specializes in producing both proprietary and generic GMP-certified peptides, which are supplied to pharmaceutical and biotechnology firms. These crucial components are integrated into approved pharmaceutical products, drugs in various stages of clinical development, and generic medications. PolyPeptide Group also handles the manufacturing of bespoke research-grade peptides and is engaged in the development of neoantigen peptides designed to advance personalized cancer therapies. Its services further encompass the production of peptides for commercially available peptide therapeutics, as well as the creation of peptide-based generics for both human and animal health sectors, alongside peptides for the cosmetics industry. Additionally, the company offers vital regulatory affairs assistance. Established in 1952, PolyPeptide Group AG maintains its corporate headquarters in Zug, Switzerland, and operates as a subsidiary of Draupnir Holding B.V.

PolyPeptide Group AG at a glance

PolyPeptide Group AG is a pharmaceuticals company headquartered in Baar, Switzerland. It is publicly listed (0AAJ) with a market capitalisation of $1.8B. Xcout tracks 13 named people at PolyPeptide Group AG, including Juan José Gonzalez (Chief Executive Officer). Xcout recorded 19 job postings from PolyPeptide Group AG in the last 90 days.

PolyPeptide Group AG leadership

  • Juan José GonzalezChief Executive Officer
  • Christina Del VecchioChief Legal Officer
  • Monika CasanovaChief Human Resources Officer
  • Raoul BernhardtChief Manufacturing and Supply Chain Officer
  • Stéphane VarrayChief Commercial Officer
  • Jon Holbech RasmussenDirector Global Quality, Development & Regulatory Affairs

7 more named people on record for PolyPeptide Group AG, with roles, board committees and tenure — see the full roster →

Hiring at PolyPeptide Group AG

Xcout recorded 19 job postings from PolyPeptide Group AG in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see PolyPeptide Group AG's hiring signals →

Recent PolyPeptide Group AG news

Top 12 PolyPeptide Group AG competitors

Ranked by semantic similarity — how close each company is to PolyPeptide Group AG by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Bora6472 · PharmaceuticalsTaipei City, Taiwan
63% matchPublic

Similar pharmaceuticals company

Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.

Market cap$1.7B
Employees2,255
Bora competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of PolyPeptide Group AG and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for PolyPeptide Group AGand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →